Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05396001 · ClinicalTrials.gov registry record · NA
LowSalt4Life: A Mobile Application to Reduce Sodium Intake And Blood Pressure
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 410
- Enrollment target
NCT05396001: Completed NA study, sponsored by University of Michigan.
NCT05396001 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 410 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05396001, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 410 participants
- Enrollment target
Study Summary
This research is being done to learn if a smartphone app with and without a just in time adaptive intervention (JITAI) can help patients with hypertension manage their sodium intake and improve their blood pressure.
Primary Outcome
SBP measured by a wireless home blood pressure monitor
Interventions
- BEHAVIORAL LowSalt4Life Application
- BEHAVIORAL Just-In-time Adaptive Intervention (JITAI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 410 participants |
| Start Date | 2022-08-15 |
| Est. Completion | 2025-10-31 |
| Phase | NA |
What the finished NCT05396001 record still lists
NCT05396001 is an interventional study that assigns participants to a tested intervention. The registered 410 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower).
The record links to 0 conditions, and to 2 interventions - of which LowSalt4Life Application is the first listed.
NCT05396001 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05396001 about?
NCT05396001 is a clinical study titled "LowSalt4Life: A Mobile Application to Reduce Sodium Intake And Blood Pressure". This research is being done to learn if a smartphone app with and without a just in time adaptive intervention (JITAI) can help patients with hypertension manage their sodium intake and improve their blood pressure.
What is the current status of trial NCT05396001?
This trial is currently completed. It is a NA study. The enrollment target is 410 participants. The study started on 2022-08-15. Estimated completion is 2025-10-31.
What interventions are being tested in trial NCT05396001?
The interventions under investigation include: LowSalt4Life Application (BEHAVIORAL), Just-In-time Adaptive Intervention (JITAI) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05396001?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05396001's enrollment target sits among peer trials
410 242nd of 2000 higher than 1,758 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02043691 · 410 participants · NA
Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies
- NCT03042975 · 410 participants
Imaging Genetics of Laryngeal Dystonia
- NCT05730036 · 410 participants · Phase 3
A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma
- NCT05751473 · 410 participants · NA
Reducing Posttraumatic Stress Disorder (PTSD) Symptoms in First Responders and Frontline Health Care Workers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI